Nitrogen Gas Springs
Nitrogen Gas Springs market is segmented by Type and by Application. Players, stakeholders, and o ... Read More
Global Oral Vaccines Market Insights and Forecast to 2028
1 Study Coverage
1.1 Oral Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Oral Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Market by Application
1.3.1 Global Oral Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Vaccines Sales by Region
2.4.1 Global Oral Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Oral Vaccines by Region (2023-2028)
2.5 Global Oral Vaccines Revenue by Region
2.5.1 Global Oral Vaccines Revenue by Region (2017-2022)
2.5.2 Global Oral Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Vaccines Sales by Manufacturers
3.1.1 Global Top Oral Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Vaccines in 2021
3.2 Global Oral Vaccines Revenue by Manufacturers
3.2.1 Global Oral Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Vaccines Revenue in 2021
3.3 Global Oral Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Vaccines Sales by Type
4.1.1 Global Oral Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Oral Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Oral Vaccines Revenue by Type
4.2.1 Global Oral Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Oral Vaccines Price by Type
4.3.1 Global Oral Vaccines Price by Type (2017-2022)
4.3.2 Global Oral Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Vaccines Sales by Application
5.1.1 Global Oral Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Oral Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Oral Vaccines Revenue by Application
5.2.1 Global Oral Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Oral Vaccines Price by Application
5.3.1 Global Oral Vaccines Price by Application (2017-2022)
5.3.2 Global Oral Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Vaccines Market Size by Type
6.1.1 North America Oral Vaccines Sales by Type (2017-2028)
6.1.2 North America Oral Vaccines Revenue by Type (2017-2028)
6.2 North America Oral Vaccines Market Size by Application
6.2.1 North America Oral Vaccines Sales by Application (2017-2028)
6.2.2 North America Oral Vaccines Revenue by Application (2017-2028)
6.3 North America Oral Vaccines Market Size by Country
6.3.1 North America Oral Vaccines Sales by Country (2017-2028)
6.3.2 North America Oral Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oral Vaccines Market Size by Type
7.1.1 Europe Oral Vaccines Sales by Type (2017-2028)
7.1.2 Europe Oral Vaccines Revenue by Type (2017-2028)
7.2 Europe Oral Vaccines Market Size by Application
7.2.1 Europe Oral Vaccines Sales by Application (2017-2028)
7.2.2 Europe Oral Vaccines Revenue by Application (2017-2028)
7.3 Europe Oral Vaccines Market Size by Country
7.3.1 Europe Oral Vaccines Sales by Country (2017-2028)
7.3.2 Europe Oral Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Vaccines Market Size by Type
8.1.1 Asia Pacific Oral Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Vaccines Market Size by Application
8.2.1 Asia Pacific Oral Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Vaccines Market Size by Region
8.3.1 Asia Pacific Oral Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oral Vaccines Market Size by Type
9.1.1 Latin America Oral Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Oral Vaccines Revenue by Type (2017-2028)
9.2 Latin America Oral Vaccines Market Size by Application
9.2.1 Latin America Oral Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Oral Vaccines Revenue by Application (2017-2028)
9.3 Latin America Oral Vaccines Market Size by Country
9.3.1 Latin America Oral Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Oral Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Vaccines Market Size by Type
10.1.1 Middle East and Africa Oral Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Vaccines Market Size by Application
10.2.1 Middle East and Africa Oral Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Vaccines Market Size by Country
10.3.1 Middle East and Africa Oral Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Corporation Information
11.4.2 Lanzhou Institute Overview
11.4.3 Lanzhou Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lanzhou Institute Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lanzhou Institute Recent Developments
11.5 Serum Institute
11.5.1 Serum Institute Corporation Information
11.5.2 Serum Institute Overview
11.5.3 Serum Institute Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Serum Institute Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Institute Recent Developments
11.6 Valneva
11.6.1 Valneva Corporation Information
11.6.2 Valneva Overview
11.6.3 Valneva Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Valneva Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Valneva Recent Developments
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Corporation Information
11.7.2 Shanghai United Cell Overview
11.7.3 Shanghai United Cell Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shanghai United Cell Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai United Cell Recent Developments
11.8 Bibcol
11.8.1 Bibcol Corporation Information
11.8.2 Bibcol Overview
11.8.3 Bibcol Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bibcol Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bibcol Recent Developments
11.9 PaxVax
11.9.1 PaxVax Corporation Information
11.9.2 PaxVax Overview
11.9.3 PaxVax Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PaxVax Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PaxVax Recent Developments
11.10 Vabiotech
11.10.1 Vabiotech Corporation Information
11.10.2 Vabiotech Overview
11.10.3 Vabiotech Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Vabiotech Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vabiotech Recent Developments
11.11 Tiantan Biological
11.11.1 Tiantan Biological Corporation Information
11.11.2 Tiantan Biological Overview
11.11.3 Tiantan Biological Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Tiantan Biological Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tiantan Biological Recent Developments
11.12 EuBiologics
11.12.1 EuBiologics Corporation Information
11.12.2 EuBiologics Overview
11.12.3 EuBiologics Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 EuBiologics Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EuBiologics Recent Developments
11.13 Panacea Biotec Ltd
11.13.1 Panacea Biotec Ltd Corporation Information
11.13.2 Panacea Biotec Ltd Overview
11.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Panacea Biotec Ltd Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Panacea Biotec Ltd Recent Developments
11.14 Bio-Med
11.14.1 Bio-Med Corporation Information
11.14.2 Bio-Med Overview
11.14.3 Bio-Med Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Bio-Med Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bio-Med Recent Developments
11.15 Halfkin Bio-Pharmaceuticals
11.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.15.2 Halfkin Bio-Pharmaceuticals Overview
11.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Vaccines Industry Chain Analysis
12.2 Oral Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Vaccines Production Mode & Process
12.4 Oral Vaccines Sales and Marketing
12.4.1 Oral Vaccines Sales Channels
12.4.2 Oral Vaccines Distributors
12.5 Oral Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Vaccines Industry Trends
13.2 Oral Vaccines Market Drivers
13.3 Oral Vaccines Market Challenges
13.4 Oral Vaccines Market Restraints
14 Key Findings in The Global Oral Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oral Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Rotavirus Vaccine
Table 3. Major Manufacturers of Cholera Vaccine
Table 4. Major Manufacturers of Oral Polio Vaccine
Table 5. Global Oral Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Oral Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Oral Vaccines Sales by Region (2017-2022) & (M Doses)
Table 8. Global Oral Vaccines Sales Market Share by Region (2017-2022)
Table 9. Global Oral Vaccines Sales by Region (2023-2028) & (M Doses)
Table 10. Global Oral Vaccines Sales Market Share by Region (2023-2028)
Table 11. Global Oral Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Oral Vaccines Revenue Market Share by Region (2017-2022)
Table 13. Global Oral Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Oral Vaccines Revenue Market Share by Region (2023-2028)
Table 15. Global Oral Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
Table 16. Global Oral Vaccines Sales Share by Manufacturers (2017-2022)
Table 17. Global Oral Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Oral Vaccines Revenue Share by Manufacturers (2017-2022)
Table 19. Oral Vaccines Price by Manufacturers (2017-2022) &(USD/K Doses)
Table 20. Global Oral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccines as of 2021)
Table 22. Oral Vaccines Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Oral Vaccines Product Offered
Table 24. Date of Manufacturers Enter into Oral Vaccines Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 27. Global Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 28. Global Oral Vaccines Sales Share by Type (2017-2022)
Table 29. Global Oral Vaccines Sales Share by Type (2023-2028)
Table 30. Global Oral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Oral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Oral Vaccines Revenue Share by Type (2017-2022)
Table 33. Global Oral Vaccines Revenue Share by Type (2023-2028)
Table 34. Oral Vaccines Price by Type (2017-2022) & (USD/K Doses)
Table 35. Global Oral Vaccines Price Forecast by Type (2023-2028) & (USD/K Doses)
Table 36. Global Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 37. Global Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 38. Global Oral Vaccines Sales Share by Application (2017-2022)
Table 39. Global Oral Vaccines Sales Share by Application (2023-2028)
Table 40. Global Oral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Oral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Oral Vaccines Revenue Share by Application (2017-2022)
Table 43. Global Oral Vaccines Revenue Share by Application (2023-2028)
Table 44. Oral Vaccines Price by Application (2017-2022) & (USD/K Doses)
Table 45. Global Oral Vaccines Price Forecast by Application (2023-2028) & (USD/K Doses)
Table 46. North America Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 47. North America Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 48. North America Oral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Oral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 51. North America Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 52. North America Oral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Oral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 55. North America Oral Vaccines Sales by Country (2023-2028) & (M Doses)
Table 56. North America Oral Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Oral Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 59. Europe Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 60. Europe Oral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Oral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 63. Europe Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 64. Europe Oral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Oral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 67. Europe Oral Vaccines Sales by Country (2023-2028) & (M Doses)
Table 68. Europe Oral Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Oral Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 71. Asia Pacific Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 72. Asia Pacific Oral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Oral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 75. Asia Pacific Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 76. Asia Pacific Oral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Oral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Oral Vaccines Sales by Region (2017-2022) & (M Doses)
Table 79. Asia Pacific Oral Vaccines Sales by Region (2023-2028) & (M Doses)
Table 80. Asia Pacific Oral Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Oral Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 83. Latin America Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 84. Latin America Oral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Oral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 87. Latin America Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 88. Latin America Oral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Oral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 91. Latin America Oral Vaccines Sales by Country (2023-2028) & (M Doses)
Table 92. Latin America Oral Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Oral Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Oral Vaccines Sales by Type (2017-2022) & (M Doses)
Table 95. Middle East and Africa Oral Vaccines Sales by Type (2023-2028) & (M Doses)
Table 96. Middle East and Africa Oral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Oral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Oral Vaccines Sales by Application (2017-2022) & (M Doses)
Table 99. Middle East and Africa Oral Vaccines Sales by Application (2023-2028) & (M Doses)
Table 100. Middle East and Africa Oral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Oral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Oral Vaccines Sales by Country (2017-2022) & (M Doses)
Table 103. Middle East and Africa Oral Vaccines Sales by Country (2023-2028) & (M Doses)
Table 104. Middle East and Africa Oral Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Oral Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 106. Merck Corporation Information
Table 107. Merck Description and Major Businesses
Table 108. Merck Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 109. Merck Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Merck Recent Developments
Table 111. GSK Corporation Information
Table 112. GSK Description and Major Businesses
Table 113. GSK Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 114. GSK Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. GSK Recent Developments
Table 116. Sanofi Corporation Information
Table 117. Sanofi Description and Major Businesses
Table 118. Sanofi Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 119. Sanofi Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Sanofi Recent Developments
Table 121. Lanzhou Institute Corporation Information
Table 122. Lanzhou Institute Description and Major Businesses
Table 123. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 124. Lanzhou Institute Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Lanzhou Institute Recent Developments
Table 126. Serum Institute Corporation Information
Table 127. Serum Institute Description and Major Businesses
Table 128. Serum Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 129. Serum Institute Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Serum Institute Recent Developments
Table 131. Valneva Corporation Information
Table 132. Valneva Description and Major Businesses
Table 133. Valneva Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 134. Valneva Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Valneva Recent Developments
Table 136. Shanghai United Cell Corporation Information
Table 137. Shanghai United Cell Description and Major Businesses
Table 138. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 139. Shanghai United Cell Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Shanghai United Cell Recent Developments
Table 141. Bibcol Corporation Information
Table 142. Bibcol Description and Major Businesses
Table 143. Bibcol Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 144. Bibcol Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Bibcol Recent Developments
Table 146. PaxVax Corporation Information
Table 147. PaxVax Description and Major Businesses
Table 148. PaxVax Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 149. PaxVax Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. PaxVax Recent Developments
Table 151. Vabiotech Corporation Information
Table 152. Vabiotech Description and Major Businesses
Table 153. Vabiotech Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 154. Vabiotech Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Vabiotech Recent Developments
Table 156. Tiantan Biological Corporation Information
Table 157. Tiantan Biological Description and Major Businesses
Table 158. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 159. Tiantan Biological Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Tiantan Biological Recent Developments
Table 161. EuBiologics Corporation Information
Table 162. EuBiologics Description and Major Businesses
Table 163. EuBiologics Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 164. EuBiologics Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. EuBiologics Recent Developments
Table 166. Panacea Biotec Ltd Corporation Information
Table 167. Panacea Biotec Ltd Description and Major Businesses
Table 168. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 169. Panacea Biotec Ltd Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Panacea Biotec Ltd Recent Developments
Table 171. Bio-Med Corporation Information
Table 172. Bio-Med Description and Major Businesses
Table 173. Bio-Med Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 174. Bio-Med Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Bio-Med Recent Developments
Table 176. Halfkin Bio-Pharmaceuticals Corporation Information
Table 177. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 178. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)
Table 179. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Halfkin Bio-Pharmaceuticals Recent Developments
Table 181. Key Raw Materials Lists
Table 182. Raw Materials Key Suppliers Lists
Table 183. Oral Vaccines Distributors List
Table 184. Oral Vaccines Customers List
Table 185. Oral Vaccines Market Trends
Table 186. Oral Vaccines Market Drivers
Table 187. Oral Vaccines Market Challenges
Table 188. Oral Vaccines Market Restraints
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Vaccines Product Picture
Figure 3. Global Oral Vaccines Market Share by Type in 2021 & 2028
Figure 3. Rotavirus Vaccine Product Picture
Figure 4. Cholera Vaccine Product Picture
Figure 5. Oral Polio Vaccine Product Picture
Figure 6. Global Oral Vaccines Market Share by Application in 2021 & 2028
Figure 7. Public
Figure 8. Private
Figure 9. Oral Vaccines Report Years Considered
Figure 10. Global Oral Vaccines Sales 2017-2028 (M Doses)
Figure 11. Global Oral Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Oral Vaccines Revenue 2017-2028 (US$ Million)
Figure 13. Global Oral Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Oral Vaccines Sales Market Share by Region (2017-2022)
Figure 15. Global Oral Vaccines Sales Market Share by Region (2023-2028)
Figure 16. North America Oral Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 17. North America Oral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Oral Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 19. Europe Oral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Oral Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 21. Asia-Pacific Oral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Oral Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 23. Latin America Oral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Oral Vaccines Sales YoY (2017-2028) & (M Doses)
Figure 25. Middle East & Africa Oral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Oral Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Oral Vaccines in the World: Market Share by Oral Vaccines Revenue in 2021
Figure 28. Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 30. Global Oral Vaccines Revenue Market Share by Type (2017-2028)
Figure 31. Global Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 32. Global Oral Vaccines Revenue Market Share by Application (2017-2028)
Figure 33. North America Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 34. North America Oral Vaccines Revenue Market Share by Type (2017-2028)
Figure 35. North America Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 36. North America Oral Vaccines Revenue Market Share by Application (2017-2028)
Figure 37. North America Oral Vaccines Sales Share by Country (2017-2028)
Figure 38. North America Oral Vaccines Revenue Share by Country (2017-2028)
Figure 39. U.S. Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 42. Europe Oral Vaccines Revenue Market Share by Type (2017-2028)
Figure 43. Europe Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 44. Europe Oral Vaccines Revenue Market Share by Application (2017-2028)
Figure 45. Europe Oral Vaccines Sales Share by Country (2017-2028)
Figure 46. Europe Oral Vaccines Revenue Share by Country (2017-2028)
Figure 47. Germany Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 48. France Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Oral Vaccines Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Oral Vaccines Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Oral Vaccines Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Oral Vaccines Revenue Share by Region (2017-2028)
Figure 58. China Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. India Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 69. Latin America Oral Vaccines Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 71. Latin America Oral Vaccines Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Oral Vaccines Sales Share by Country (2017-2028)
Figure 73. Latin America Oral Vaccines Revenue Share by Country (2017-2028)
Figure 74. Mexico Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Oral Vaccines Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Oral Vaccines Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Oral Vaccines Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Oral Vaccines Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Oral Vaccines Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Oral Vaccines Revenue Share by Country (2017-2028)
Figure 83. Turkey Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Oral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 86. Oral Vaccines Value Chain
Figure 87. Oral Vaccines Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck GSK Sanofi Lanzhou Institute Serum Institute Valneva Shanghai United Cell Bibcol PaxVax Vabiotech Tiantan Biological EuBiologics Panacea Biotec Ltd Bio-Med Halfkin Bio-Pharmaceuticals